Does MOTS-c act as a transcription factor?

It regulates nuclear gene expression, but describing it as a transcription factor overstates what was reported. Its precise role at the promoter is not fully characterised.

What triggers the move to the nucleus?

Metabolic stress. The behaviour is conditional rather than constitutive, which is part of why it reads as a signalling event.

Is this unique among mitochondrial peptides?

It is the clearest demonstrated case. Whether humanin or the SHLPs do anything comparable is not established.

MOTS-c (Mitochondrial Peptide)

MOTS-c Nuclear Translocation Under Metabolic Stress

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-232 cited sources

Kim, Son and Benayoun reported in Cell Metabolism in September 2018 that MOTS-c translocates from the mitochondrion to the nucleus in response to metabolic stress, where it regulates nuclear gene expression including antioxidant response element-containing genes. This is a peptide encoded in mitochondrial DNA acting on the nuclear genome.

Key facts

Publication: Cell Metabolism, 4 September 2018
PMID: 29983246
Authors: Kim KH, Son JM, Benayoun BA et al.
Trigger: Metabolic stress (e.g. glucose restriction, oxidative stress)
Destination: Nucleus
Target genes: Antioxidant response element (ARE)-containing
Concept: Mitochondrial retrograde signalling

What retrograde signalling means

The nucleus controls the mitochondrion — most mitochondrial proteins are nuclear-encoded and imported. Signalling in the other direction, from mitochondrion to nucleus, is called retrograde signalling, and it was historically understood to work through indirect intermediates such as calcium, reactive oxygen species or metabolite levels. A peptide encoded in mitochondrial DNA physically entering the nucleus and acting on transcription is a much more direct channel.

What the study reported

Under metabolic stress, MOTS-c was observed to move into the nucleus rather than remaining associated with the mitochondrion. There it participated in regulating expression of nuclear genes, with the antioxidant response element-containing set specifically identified. The behaviour was conditional on stress rather than constitutive, which is what makes it look like signalling rather than distribution.

Research material referenced

MOTS-C 10mg — third-party HPLC tested

View — £24.99

Why the ARE genes are the notable target

Antioxidant response elements are the promoter sequences through which the cell coordinates its response to oxidative stress. Mitochondria are the principal endogenous source of reactive oxygen species. A peptide originating in the organelle that generates the stress, acting on the nuclear programme that responds to it, is a coherent feedback architecture rather than an isolated observation.

How it fits with the AMPK mechanism

These are two separate reported activities and they should not be conflated. AMPK activation via folate-cycle inhibition is a cytosolic, metabolite-mediated effect. Nuclear translocation is a distinct behaviour under a distinct trigger. Whether they are mechanistically connected, and how, is not settled by the published work.

Reading this carefully

This is cell-biological work, and it describes what the peptide does inside cells under defined stress conditions. It says nothing about outcomes in an organism, and nothing about what administering the peptide would do. The finding is interesting because of what it reveals about mitochondrial-nuclear communication, which is a different kind of claim entirely.

Extended research context

The MOTS-c (Mitochondrial Peptide) deep dive

Deep dive: why a peptide encoded in mitochondrial DNA is unusual

The human mitochondrial genome is 16,569 base pairs encoding 37 genes, and was considered fully characterised by the 1980s: thirteen respiratory-chain proteins, twenty-two transfer RNAs, two ribosomal RNAs. MOTS-c is encoded by a short open reading frame nested inside the 12S rRNA gene — sequence already annotated as doing something else, which is exactly why it went unnoticed. Humanin, found in 2001 inside the 16S rRNA gene, established that the genome held more than its annotation suggested; MOTS-c was found in 2015 by looking deliberately. The implication is that the mitochondrion encodes and releases signalling molecules of its own, rather than only executing instructions sent from the nucleus.

Deep dive: AMPK activation without touching AMPK

AMPK is normally activated when AMP and ADP bind its gamma subunit, making it a direct sensor of the AMP-to-ATP ratio. MOTS-c does not raise that ratio and does not bind the kinase. It inhibits the folate cycle, the one-carbon pathway feeding de novo purine biosynthesis, and the intermediate AICAR accumulates as a result. AICAR is an AMP mimetic — phosphorylated to ZMP, it binds the same regulatory site AMP occupies. So the peptide reaches a cytosolic energy sensor through one-carbon metabolism and a diffusible small molecule, which is a materially different architecture from a receptor-ligand interaction, and different again from metformin's inhibition of complex I.

Deep dive: reading a preclinical literature honestly

Roughly 250 indexed papers exist, and the overwhelming majority are cell and rodent studies. Where humans appear, the work is generally observational: measuring circulating concentrations and correlating them with age, fitness or metabolic state. The 2021 Nature Communications paper is the clearest example of the structure — the human arm measured MOTS-c before and after exercise, finding roughly a 12-fold rise in skeletal muscle against 1.6-fold in circulation, while the interventional work was done in mice. Two inferences the secondary literature routinely makes and the primary literature does not support: that a correlation between low concentrations and poor metabolic health establishes direction, and that a molecule which rises during exercise would reproduce exercise if administered.

Research applications

▸Study of mitochondrial-derived peptides and retrograde signalling
▸AMPK pathway research through non-canonical activation
▸One-carbon and folate-cycle metabolism models
▸Exercise physiology and mitochondrial bioenergetics research
▸Ageing biology and mitochondrial genome expression studies

Handling checklist

✓Store lyophilised material cold, dry and protected from light
✓Expect methionine oxidation as the primary degradation route (+16 Da per residue)
✓No reducing agent needed — the sequence contains no cysteine
✓Introduce diluent gently against the vial wall; swirl rather than shake
✓Aliquot to avoid repeated freeze-thaw cycles
✓Check mass spectrometry for +16 and +32 satellites before relying on a batch

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Reading exercise induction as proof that administration mimics exercise

Fix: The papers report that exercise raises MOTS-c. The reverse inference is not supported and is not claimed.

✗ Treating human observational data as interventional evidence

Fix: Human work measures endogenous concentrations; administration studies were conducted in mice.

✗ Assuming MOTS-c has a cell-surface receptor like humanin

Fix: No receptor is established. Its characterised activity is intracellular.

✗ Storing reconstituted material as though it were as stable as the powder

Fix: Solution-phase material is subject to hydrolysis and oxidation; the lyophilised form is far more stable.

✗ Overlooking WADA status in athlete-adjacent research

Fix: MOTS-c is on the prohibited list; this is relevant to any research context involving competitors.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

Does MOTS-c act as a transcription factor?: It regulates nuclear gene expression, but describing it as a transcription factor overstates what was reported. Its precise role at the promoter is not fully characterised.
What triggers the move to the nucleus?: Metabolic stress. The behaviour is conditional rather than constitutive, which is part of why it reads as a signalling event.
Is this unique among mitochondrial peptides?: It is the clearest demonstrated case. Whether humanin or the SHLPs do anything comparable is not established.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

More MOTS-c (Mitochondrial Peptide) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum